P38 mitogen-activated protein kinase promotes dedifferentiation of primary articular chondrocytes in monolayer culture

Journal of Cellular and Molecular Medicine

Volumn 17, Issue 4, 2013, Pages 508-517

  Rosenzweig, Derek H ^a   Ou, Sing J ^a   Quinn, Thomas M ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Chondrocyte; Dedifferentiation; Extra Cellular Matrix; Gene Expression; MAPK; Signal Transduction

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2-(2-AMINO-3-METHOXYPHENYL)-4H-1-BENZOPYRAN-4-ONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA(1,9 CD)PYRAZOL 6(2H) ONE; ANTHRA(1,9-CD)PYRAZOL-6(2H)-ONE; ANTHRACENE DERIVATIVE; FLAVONOID; GLYCOSAMINOGLYCAN; IMIDAZOLE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE INHIBITOR; PYRIDINE DERIVATIVE;

ANIMAL; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CATTLE; CELL DEDIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CHONDROGENESIS; CYTOLOGY; DRUG ANTAGONISM; EXTRACELLULAR MATRIX; GENE EXPRESSION; METABOLISM; PHENOTYPE; PHYSIOLOGY; PRIMARY CELL CULTURE; SECRETION (PROCESS); SIGNAL TRANSDUCTION;

ANIMALS; ANTHRACENES; CARTILAGE, ARTICULAR; CATTLE; CELL DEDIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CHONDROCYTES; CHONDROGENESIS; EXTRACELLULAR MATRIX; FLAVONOIDS; GENE EXPRESSION; GLYCOSAMINOGLYCANS; IMIDAZOLES; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHENOTYPE; PRIMARY CELL CULTURE; PROTEIN KINASE INHIBITORS; PYRIDINES;

EID: 84877040116     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12034     Document Type: Article

References (44)

1. Bhosale AM, Richardson JB. Articular cartilage: structure, injuries and review of management. Br Med Bull. 2008; 87: 77-95.
2. Anderson DD, Chubinskaya S, Guilak F, et al. Post-traumatic osteoarthritis: improved understanding and opportunities for early intervention. J Orthop Res. 2011; 29: 802-9.
3. Natoli RM, Athanasiou KA. Traumatic loading of articular cartilage: mechanical and biological responses and post-injury treatment. Biorheology. 2009; 46: 451-85.
4. O'Driscoll SW. The healing and regeneration of articular cartilage. J Bone Joint Surg Am. 1998; 80: 1795-812.
5. Brittberg M, Lindahl A, Nilsson A, et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. New Eng J Med. 1994; 331: 889-95.
6. Batty L, Dance S, Bajaj S, et al. Autologous chondrocyte implantation: an overview of technique and outcomes. ANZ J Surg. 2011; 81: 18-25.
7. Brittberg M. Cell carriers as the next generation of cell therapy for cartilage repair: a review of the matrix-induced autologous chondrocyte implantation procedure. Am J Sports Med. 2010; 38: 1259-71.
8. Kino-Okaa M, Maedaa Y, Yamamotob T, et al. A kinetic modeling of chondrocyteculture for manufacture of tissue-engineered cartilage. J Biosci Bioeng. 2005; 100: 197-207.
9. Aulthouse AL, Beck M, Griffer E, et al. Expression of the human chondrocyte phenotype in vitro. In Vitro Cell Develop Biol. 1989; 25: 659-68.
10. Darling EM, Athanasiou KA. Rapid phenotypic changes in passaged articular chondrocyte subpopulations. J Orthop Res. 2005; 23: 425-32.
11. Lin Z, Fitzgerald JB, Xu J, et al. Gene expression profiles of human chondrocytes during passaged monolayer cultivation. J Orthop Res. 2008; 26: 1230-7.
12. Eid K, Thornhill TS, Glowacki J. Chondrocyte gene expression in osteoarthritis: correlation with disease severity. J Orthop Res. 2006; 24: 1062-8.
13. Lefebvre V, Peeters-Joris C, Vaes G. Production of collagens, collagenase and collagenase inhibitor during the dedifferentiation of articular chondrocytes by serial subcultures. Biochim Biophys Acta. 1990; 1051: 266-75.
14. Giovannini S, Diaz-Romero J, Aigner T, et al. Population doublings and percentage of S100-positive cells as predictors of in vitro chondrogenicity of expanded human articular chondrocytes. J Cell Physiol. 2010; 222: 411-20.
15. Chun JS. Expression, activity, and regulation of MAP kinases in cultured chondrocytes. Methods Mol Med. 2004; 100: 291-306.
16. Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 2002; 298: 1911-2.
17. Kim SJ, Ju JW, Oh CD, et al. ERK-1/2 and p38 kinase oppositely regulate nitric oxide-induced apoptosis of chondrocytes in association with p53, caspase-3, and differentiation status. J Biol Chem. 2002; 277: 1332-9.
18. Yoon YM, Kim SJ, Oh CD, et al. Maintenance of differentiated phenotype of articular chondrocytes by protein kinase C and extracellular signal-regulated protein kinase. J Biol Chem. 2002; 277: 8412-20.
19. Rosenzweig DH, Matmati M, Khayat G, et al. Culture of primary bovine chondrocytes on a continuously expanding surface inhibits dedifferentiation. Tissue Eng Part A. 2012; 18 (23-24): 2466-76.
20. Rosenzweig DH, Solar-Cafaggi S, Quinn TM. Functionalization of dynamic culture surfaces with a cartilage extracellular matrix extract enhances chondrocyte phenotype against dedifferentiation. Acta Biomater. 2012; 8: 3333-41.
21. Bernstein P, Sticht C, Jacobi A, et al. Expression pattern differences between osteoarthritic chondrocytes and mesenchymal stem cells during chondrogenic differentiation. Osteoarthritis Cartilage. 2010; 18: 1596-607.
22. Majd H, Wipff PJ, Buscemi L, et al. A novel method of dynamic culture surface expansion improves mesenchymal stem cell proliferation and phenotype. Stem Cells. 2009; 27: 200-9.
23. Zhang Z, McCaffery JM, Spencer RG, et al. Hyaline cartilage engineered by chondrocytes in pellet culture: histological, immunohistochemical and ultrastructural analysis in comparison with cartilage explants. J Anat. 2004; 205: 229-37.
24. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25: 402-8.
25. Bosnakovski D, Mizuno M, Kim G, et al. Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: influence of collagen type II extracellular matrix on MSC chondrogenesis. Biotechnol Bioeng. 2006; 93: 1152-63.
26. Radons J, Bosserhoff AK, Grassel S, et al. p38MAPK mediates IL-1-induced down-regulation of aggrecan gene expression in human chondrocytes. Int J Mol Med. 2006; 17: 661-8.
27. Huh YH, Kim SH, Kim SJ, et al. Differentiation status-dependent regulation of cyclooxygenase-2 expression and prostaglandin E2 production by epidermal growth factor via mitogen-activated protein kinase in articular chondrocytes. J Biol Chem. 2003; 278: 9691-7.
28. Rosenzweig DH, Djap MJ, Ou SJ, et al. Mechanical injury of bovine cartilage explants induces depth-dependent, transient changes in MAP kinase activity associated with apoptosis. Osteoarthritis Cartilage. 2012; 20: 1591-602.
29. Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. FASEB J. 2004; 18: 816-27.
30. Kloesch B, Liszt M, Steiner G, et al. Inhibitors of p38 and ERK1/2 MAPkinase and hydrogen sulphide block constitutive and IL-1beta-induced IL-6 and IL-8 expression in the human chondrocyte cell line C-28/I2. Rheumatol Int. 2012; 32: 729-36.
31. Studer RK, Bergman R, Stubbs T, et al. Chondrocyte response to growth factors is modulated by p38 mitogen-activated protein kinase inhibition. Arthritis Res Ther. 2004; 6: R56-64.
32. Lim H, Kim HP. Matrix metalloproteinase-13 expression in IL-1beta-treated chondrocytes by activation of the p38 MAPK/c-Fos/AP-1 and JAK/STAT pathways. Arch Pharm Res. 2011; 34: 109-17.
33. Tew SR, Clegg PD, Brew CJ, et al. SOX9 transduction of a human chondrocytic cell line identifies novel genes regulated in primary human chondrocytes and in osteoarthritis. Arthritis Res Ther. 2007; 9: R107.
34. Thalhamer T, McGrath MA, Harnett MM. MAPKs and their relevance to arthritis and inflammation. Rheumatology. 2008; 47: 409-14.
35. Westra J, Doornbos-van der Meer B, de Boer P, et al. Strong inhibition of TNF-alpha production and inhibition of IL-8 and COX-2 mRNA expression in monocyte-derived macrophages by RWJ 67657, a p38 mitogen-activated protein kinase (MAPK) inhibitor. Arthritis Res Ther. 2004; 6: R384-92.
36. Westra J, Limburg PC, de Boer P, et al. Effects of RWJ 67657, a p38 mitogen activated protein kinase (MAPK) inhibitor, on the production of inflammatory mediators by rheumatoid synovial fibroblasts. Ann Rheum Dis. 2004; 63: 1453-9.
37. Sondergaard BC, Schultz N, Madsen SH, et al. MAPKs are essential upstream signaling pathways in proteolytic cartilage degradation-divergence in pathways leading to aggrecanase and MMP-mediated articular cartilage degradation. Osteoarthritis Cartilage. 2010; 18: 279-88.
38. Reilly GC, Golden EB, Grasso-Knight G, et al. Differential effects of ERK and p38 signaling in BMP-2 stimulated hypertrophy of cultured chick sternal chondrocytes. Cell Commun Signal. 2005; 3: 3.
39. Takebe K, Nishiyama T, Hayashi S, et al. Regulation of p38 MAPK phosphorylation inhibits chondrocyte apoptosis in response to heat stress or mechanical stress. Int J Mol Med. 2011; 27: 329-35.
40. Hong EH, Yun HS, Kim J, et al. Nicotinamide phosphoribosyltransferase is essential for IL-1{beta}-mediated dedifferentiation of articular chondrocytes via SIRT1 and ERK complex signaling. J Biol Chem. 2011; 286: 28619-31.
41. Chow G, Nietfeld JJ, Knudson CB, et al. Antisense inhibition of chondrocyte CD44 expression leading to cartilage chondrolysis. Arthritis Rheum. 1998; 41: 1411-9.
42. Majd H, Quinn TM, Wipff PJ, et al. Dynamic expansion culture for mesenchymal stem cells. Methods Mol Biol. 2011; 698: 175-88.
43. Horbelt D, Denkis A, Knaus P. A portrait of Transforming Growth Factor beta superfamily signalling: background matters. Int J Biochem Cell Biol. 2012; 44: 469-74.
44. Wang L, Ma R, Flavell RA, et al. Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for activation of p38alpha and p38delta MAPK isoforms by TGF-beta 1 in murine mesangial cells. J Biol Chem. 2002; 277: 47257-62.